Compare Mutual Funds
Pros | 3Y returns in the top 25% of the category. Beats FD returns for both 3Y & 5Y duration. | Larger AUM within category. Beats FD returns for both 3Y & 5Y duration. | ||
Cons | - | 5Y returns in the bottom 25% of the category. 3Y returns in the bottom 25% of the category. |
INDMoney rank | 4/10 | 10/10 | ||
Category | Equity, Sector - Healthcare | Equity, Sector - Healthcare | ||
Fund Age | 14 Years | 14 Years | ||
Fund AUM | ₹1430 Cr | ₹9166 Cr | ||
Min Investment |
|
| ||
Expense Ratio | 1.34% | 1% | ||
Exit Load | 1% | 1% | ||
Benchmark Index | BSE Healthcare TR INR | BSE Healthcare TR INR |
No of Holdings | 46 | 40 | ||
Top 5 Holdings |
|
| ||
No of Sectors | 1 | 1 | ||
Top 3 Sectors | Health (100%) | Health (100%) | ||
Equity % | 94.12% | 97.3% | ||
Debt % | - | - | ||
P/E | 38.71 | 37.98 | ||
P/B | 5.38 | 5.6 | ||
Credit Quality | - | - | ||
Modified Duration | - | - | ||
YTM | - | - |
1-Month Return | -1.26% | -0.76% | ||
3-Month Return | -1.4% | -2.52% | ||
6-Month Return | 12.8% | 7.84% | ||
1-Year Return | 13.46% | 9.05% | ||
3-Year Return | 23.47% | 18.56% | ||
5-Year Return | 16.24% | 14.19% |
Sharpe | 1.03 | 0.83 | ||
Alpha | 0.9 | -2.19 | ||
Beta | 0.96 | 0.89 | ||
Standard Deviation | 16 | 14.87 | ||
Information Ratio | 0.13 | -1.14 |
Description | UTI Healthcare Fund is an equity fund.The fund could potentially beat inflation in the long-run. | Nippon India Pharma Fund is an equity fund.The fund could potentially beat inflation in the long-run. | ||
Managers | Kamal Gada | Kinjal Desai, Amber Singhania, Sailesh Raj Bhan |

